Familial defective apolipoprotein B-100: A review.

Lars H Andersen, André R Miserez, Zahid Ahmad, Rolf L Andersen

Journal: Journal of clinical lipidology 2017;10(6):1297-1302

PMID: 27919345

Abstract

Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder of lipid metabolism associated with hyperlipidemia and elevated risk for atherosclerosis. FDB is caused by mutations in APOB reducing the binding affinity between apolipoprotein B-100 and the low-density lipoprotein receptor. Population studies suggest that approximately 0.1% of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. However, the elevation of plasma low-density lipoprotein cholesterol observed in FDB is frequently milder than that of FH due to mutations in LDLR, and FDB is subsequently underdiagnosed according to standard FH diagnostic criteria.

Copyright © 2016 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Address: Department of Clinical Research, Lancaster General Health/Penn Medicine, Lancaster, PA, USA. Electronic address: [email protected].; Department of Biomedicine, University of Basel, Basel, Switzerland; Department of Molecular Medicine, diagene Laboratories Inc, Research Institute, Reinach, Switzerland.; Division of Nutrition and Metabolic Disease, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Preventive Cardiology and Apheresis Clinic, Division of Cardiology, Lancaster General Health/Penn Medicine, Lancaster, PA, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.